²úÎï·ÖÀà
Product CategoryÏêϸ½éÉÜ
Æ·ÅÆ | ³¢¾±´Ú±ð-¾±³¢²¹²ú/Àî¼ÇÉúÎï |
---|
±á9³¦2£¨´óÊóÐļ¡Ï¸°û£©ÃèÊö
H9c2£¨ÖÐÎÄÃû³Æ£º´óÊóÐļ¡Ï¸°û£©£¬À´Ô´ÓÚ´óÊóÐÄÔ࣬Õý³£µÄϸ°ûÐÎ̬Ϊ³É¼¡Ï¸°ûÑù£¬Ìù±ÚÉú³¤¡£
¶©¹ºÐÅÏ¢
²úÎïÃû³Æ | »õºÅ | ¹æ¸ñ |
H9c2 | AX41L235 | T25/1 mL |
ÔËÊ䷽ʽ
³£ÎÂ/¸É±ùÔËÊä¡£
±á9³¦2£¨´óÊóÐļ¡Ï¸°û£©Ê¹Ó÷½·¨
ÅàÑø·½·¨
ÅàÑø»ù | DMEM£¨GIBCO: C11965500BT£©90%, Fetal Bovine Serum(GIBCO:10099-141)»òºÍÔªÀî¼ÇÌØ¼¶Ì¥Å£ÑªÇå (Foetal Bovine Serum)£¨»õºÅ£ºAC03L055£© 10% |
ÅàÑøÌõ¼þ | 37¡æ 5% CO2 |
Ïû»¯Ìõ¼þ | 0.25% Trypsin- EDTA(GIBCO: 25200-056) »òºÍÔªÀî¼Ç0.25%Òȵ°µÄ°×øÏû»¯Òº£¨º¬EDTA£¬²»º¬·Óºì£©£¨»õºÅ£ºAC15L821£©£¬Ïû»¯1-3min |
´«´ú±ÈÀý | 1£º2-1£º4 |
»»ÒºÊ±¼ä | 2-3Ìì»»ÒºÒ»´Î |
¶³´æ·½·¨
¶³´æÒº | 55%ÅàÑø»ù£¬40%FBS, 5% (v/v) DMSO »ò ºÍÔªÀî¼Ç¿ìËÙϸ°û¶³´æÒº£¨ÎÞѪÇå¡¢ÎÞµ°°×£©£¨»õºÅ£ºAC05L033£© |
¶³´æÃÜ¶È | 1-3 ¡Á106 /¹Ü£¬Òºµª±£´æ |
¡¡ ¾ßÌå²Ù×÷·½·¨¼ûϸ°ûʹÓÃ˵Ã÷Êé
×¢ÒâÊÂÏî
±¾²úÎï½öÏÞÓÚ¿ÆÑ§ÊµÑéÑо¿Ê¹Ó㬲»µÃÓÃÓÚÁÙ´²Õï¶Ï¡¢ÖÎÁƵÈÁìÓò¡£
µ±ÊÕµ½Ï¸°ûºó£¬Çë×ÐϸÔĶÁϸ°ûʹÓÃ˵Ã÷Ê飬°´¹æ¶¨²Ù×÷²¢¼Ç¼ϸ°û״̬£¨ÅÄÕÕ£©¡£ÎÒ˾Ϊ¿Í»§ÌṩһÖÜÄÚµÄÊÛºó±£ÕÏ¡£
²Î¿¼ÎÄÏ×
Kimes BW, Brandt BL. Properties of a clonal muscle cell line from rat heart. Exp. Cell Res. 98: 367-381, 1976. PubMed: 943302
Levy AP, et al. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271: 2746-2753, 1996. PubMed: 8576250
Ïà¹Ø²úÎïÍÆ¼ö
ÌØ¼¶Ì¥Å£ÑªÇå (Foetal Bovine Serum)£¨»õºÅ£ºAC03L055£©
RPMI-1640 medium (º¬L-¹È°±µÄõ£°·)£¨»õºÅ£ºAC01L064£©
±¾²úÎï½öÏÞÓÚ¿ÆÑ§ÊµÑéÑо¿Ê¹Ó㬲»µÃÓÃÓÚÁÙ´²Õï¶Ï¡¢ÖÎÁƵÈÁìÓò¡£
²úÎï×Éѯ
µç»°
΢ÐÅ×Éѯ
¹Ø×¢¹«ÖÚºÅ